Meldofsky Firm LLC Discusses the Allegations That Xarelto May Cause Ischemic Stroke in Patients with Atrial Fibrillation

One of the latest lawsuits filed against the manufacturers and distributors of Xarelto was filed just lately in Philadelphia, Pennsylvania. As a matter of fact, Pennsylvania is the very first to make allegations against the Drug that is absolutely ineffective and useless in preventing ischemic strokes and that the drug may actually be the one to cause it especially in patients who have been found out to have atrial fibrillation even in the prescribed once a day dosage.

Logo

Lake Forest, CA -- (SBWire) -- 10/26/2015 --There have been so many allegations that have been coming out that what Janssen Pharmaceuticals and Bayer Health Care claim to be the newest wonder anticoagulant drug; Xarelto is not at all effective so they say. In line with this, one of the latest lawsuits filed against the manufacturers and distributors of Xarelto was filed just lately in Philadelphia, Pennsylvania. As a matter of fact, Pennsylvania is the very first to make allegations against the Drug that is absolutely ineffective and useless in preventing ischemic strokes and that the drug may actually be the one to cause it especially in patients who have been found out to have atrial fibrillation even in the prescribed once a day dosage.

Xarelto has been approved for distribution and consumption by the Food and Drugs Administration and has been prescribed by many professional health practitioners using the 2 types of preparations or strengths which are the 15 milligrams that can be used 2 times a day and the 20 milligrams used as a single daily dose. Some people have tolerated the 2 times a day frequency. However, since there have been complaints that led to lawsuits that Xarelto causes severe bleeding tendencies, the company marketing this anticoagulant has advised doctors and pharmacists to practice extreme caution when prescribing and dispensing the drug to its users.

All Xarelto lawsuits that have been filed nationwide in various federal courts shall be consolidated in the Eastern District of Louisiana before the respectable Judge Eldon E. Fallon based on the announcement of the United States Judicial Panel on Multidistrict Litigation. Moreover, several thousands of Xarelto cases are projected to be transferred to the MDL.

All the complaints revolve around the issue that the manufacturers and distributors of Xarelto:

- Failed at warning the general public about the all the possible adverse effects and risks that Xarelto may cause profuse and uncontrolled internal hemorrhage.

- That Johnson and Johnson failed in the formulation of any approved antidote to counteract the effects of this anticoagulant in the event that adverse reactions start to appear in patients.

- That the makers of Xarelto have done false and deceptive claims that the drug is the superior form of anticoagulant and that it is the best alternative for Warfarin, which is then the best of its kind before the launch of Xarelto.

Advisories were released that only in the initial phase of the treatment, that Xarelto has to be taken twice a day by first-time users and the dosage must be strictly adjusted to be taken in a single dose per day to prevent adverse effects. It was just lately that the information was released by the experts behind the manufacturing and distribution of Xarelto; only after there have been massive complaints and cases filed by the Xarelto users and their families.

Bottomline is that Xarelto, being claimed to be the best anticoagulant drug in the market today is facing a substantial number of complaints that have legally been filed against the companies involved in its production and marketing. And up to the present, lawsuits are continuously increasing and is expected to increase further in the near future. Xarelto's effectiveness is also in question at this point because of the incidences that it may actually aggravate certain conditions that have lead to ischemic strokes, profuse bleedings and even death to some of its users.

About Meldofsky Firm LLC
The Meldofsky Firm LLC is a law firm located in Lake Forest, CA aims to help people who are in need for legal assistance. The law firm is manned by exceptional professional competent lawyers who provide their clients with legal representations even of clients residing outside California. The Meldofsky Law Firm provides legal assistance with claims and compensation in cases of medication-related court cases like the Xarelto Lawsuit.

Contact:
Dimitry Vital
PR and Marketing @ Meldofsky Firm LLC
Telephone: 877-274-8672
Website: http://xareltoinjurylawsuits.info/

Media Relations Contact

Galin Georgiev
877-274-8672
http://xareltoinjurylawsuits.info/

View this press release online at: http://rwire.com/636044